Word

PREVIFENON

Status

Dead

Status Code

606

Status Date

Monday, July 18, 2022

Serial Number

90031217

Mark Type

4000

Filing Date

Wednesday, July 1, 2020

Published for Opposition

Tuesday, April 20, 2021

Abandoned Date

Monday, July 18, 2022

Trademark Owner History

MELISA Institute Genomics & Proteomics Research SpA - Owner At Publication

Classifications

5 Contrast media for in vivo imaging; Sanitary panties; Pharmaceutical preparations for treating and prevention of respiratory diseases and disorders; Pharmaceutical preparations for the treatment and prevention of viral respiratory infectious diseases; Pharmaceutical preparations for the treatment or prevention of disorders or diseases caused by bacteria, namely, antibiotics; Pharmaceutical preparations for the prevention of diseases of the respiratory system; Pharmaceutical preparations for the prevention of diseases and disorders of the immune system; Pharmaceutical products for the prevention and treatment of cognitive and intellectual deficit disorders, delays in psychomotor neurodevelopment, gestational disorders, hypertension, viral infections, sexually transmitted diseases, diseases caused by fungal infections, neoplasms and cancer

The wording ¿PREVIFENON¿ has no meaning in a foreign language.

Trademark Events

Jul 18, 2022

Abandonment Notice E-Mailed - No Use Statement Filed

Jul 18, 2022

Abandonment - No Use Statement Filed

Dec 9, 2021

Notice Of Approval Of Extension Request E-Mailed

Dec 7, 2021

Sou Extension 1 Granted

Dec 7, 2021

Sou Extension 1 Filed

Dec 7, 2021

Sou Teas Extension Received

Jun 15, 2021

Noa E-Mailed - Sou Required From Applicant

Apr 20, 2021

Official Gazette Publication Confirmation E-Mailed

Apr 20, 2021

Published For Opposition

Mar 31, 2021

Notification Of Notice Of Publication E-Mailed

Mar 16, 2021

Approved For Pub - Principal Register

Mar 16, 2021

Examiner's Amendment Entered

Mar 16, 2021

Assigned To Lie

Mar 16, 2021

Notification Of Examiners Amendment E-Mailed

Mar 16, 2021

Examiners Amendment E-Mailed

Mar 16, 2021

Examiners Amendment -Written

Mar 15, 2021

Teas/Email Correspondence Entered

Mar 15, 2021

Correspondence Received In Law Office

Mar 15, 2021

Teas Response To Office Action Received

Oct 6, 2020

Notification Of Non-Final Action E-Mailed

Oct 6, 2020

Non-Final Action E-Mailed

Oct 6, 2020

Non-Final Action Written

Oct 6, 2020

Assigned To Examiner

Jul 29, 2020

New Application Office Supplied Data Entered

Jul 4, 2020

New Application Entered